Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ioflupane
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : PPD
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Radiolabeled Compounds
Upfront Cash : Inapplicable
September 25, 2020
Lead Product(s) : Ioflupane
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : PPD
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Radiolabeled Compounds
Upfront Cash : Inapplicable
December 10, 2019